Consumption Rooms Research Articles

Can drug consumption rooms reduce drug-related harm?

Can drug consumption rooms reduce drug-related harm?

UK's first safe drug consumption room approved to open in Glasgow

UK's first safe drug consumption room approved to open in Glasgow

Drugs: minors and harm reduction?

The use of controlled substances (narcotics and psychotropic substances) poses increased risks for minors. However, minors are generally excluded from existing harm reduction services (e.g. drug consumption rooms, drug checking, exchange of consumption material). Based on public health considerations, the authors recommend the establishment of harm reduction services for minors.

Moderation and coexistence with psychoactive substances use: Approaching a Drug Consumption Room in France

Este artigo objetivou compreender como é, para usuários psicoativos, experienciar o uso de substância em uma Sala de Consumo de Drogas (SCD) para redução de danos e como isso impacta suas vidas e subjetividades. O trabalho parte da premissa de que a polêmica implementação das SCDs é uma tentativa de resposta ao processo social que transformou o uso de substâncias psicoativas em crime/problema de saúde e criou a categoria patológica, excludente e punível de usuário/dependente de drogas. Foi utilizada uma metodologia qualitativa mesclando entrevistas e observação direta da SCD de Estrasburgo (ARGOS). Os resultados mostram que os usuários de psicoativos que frequentam esta estrutura se encontram persistentemente atrelados à higiene, responsabilidade e culpa, sinalizando uma busca por adesão à ordem social intercalada com o uso de substâncias, contudo, ainda atravessada por sentimentos controversos relacionados ao seu consumo. Também expressando sua autonomia, os usuários reformulam os significados que atribuem ao seu consumo de substâncias e a si mesmos. Além disso, a sensibilidade da SCD de Estrasburgo face à precariedade de seu público dá pistas para se refletir sobre essa estrutura como um agente que atua por convicção diante da tragédia em que vive esta população.

Salles de consommation à moindre risque : opinion et volonté d'utilisation des personnes injectrices de substances psychoactives à Marseille, France

BackgroundIn France, people who inject drugs (PWID) are still one of the most at risk population for contracting hepatitis C virus (HCV). Drug consumption rooms (DCR) have shown their effectiveness on HCV risk behaviors abroad and in France, where they have been recently evaluated with the COSINUS study. In France, two DCRs opened in 2016, one in Paris and another in Strasbourg. The objective of this sub-analysis was to explore the willingness to use a DCR in PWID living in Marseille, where no DCR is opened. MethodsThe COSINUS study is a prospective multicenter cohort that included 665 PWID recruited in Bordeaux, Marseille, Paris and Strasbourg between 2016 and 2019. Investigators administered questionnaires face-to-face at regular intervals at baseline, 3 months, 6 months and 12 months. In Marseille, 199 PWID were recruited. A multivariable logistic regression model was performed to assess factors associated with willingness to use DCR among this population. ResultsAmong 545 observations corresponding to 195 distinct participants selected for analyses, 57% declared they were willing to attend a DCR. The main reason given was “to consume more cleanly”. Receiving allowances (OR = 2.38; 95% confidence interval (CI) (95% CI) = 1.17–4.81), not having health insurance (OR = 3.61; 95% CI = 1.49–8.75), injecting daily (OR = 1.97; 95% CI = 1.05–3.70) and in a public space (OR = 2.66; 95% CI = 1.29–5.47) were all positively associated with willingness to use a DCR. ConclusionsDCR are devices that target PWID exposed to high sanitary or social risks, i.e. people living in precarious conditions, who have to inject in public spaces, in deleterious sanitary environments and with rapid gestures in order not to be seen. These analyzes highlight that the people who most want to attend a DCR are aware of the harms associated with their practices and show a desire to seek protection from street-based drug scenes.

Community perceptions surrounding Lisbon's first mobile drug consumption room.

Portugal's first Mobile Drug Consumption Room (MDCR) has been operating for over three years in two Lisbon neighborhoods. This qualitative study first creates a baseline understanding of community perceptions concerning the acceptability of and expectations surrounding drug consumption rooms in the communities of intervention. Then, at least six months after the initial interviews, it determines how these perceptions changed and what changes participants perceive in the neighborhoods. Findings highlight widespread acceptance of the MDCR among participants. One of the participants' priorities related to the MDCR was to lessen the visibility of public consumption, a change some participants perceived in the neighborhood. While in the first round of data collection participants primarily conceptualized the MDCR as a service for People Who Use Drugs (PWUD), in the follow-up round, they reported changes in the community.

Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020).

Hepatitis C virus (HCV) and HIV remain prevalent among people who inject drugs (PWID) and transmission is usually associated with injecting risk behaviour (IRB). We update a 2011 review of reviews (RoR) to assess the latest evidence on the effectiveness of harm reduction interventions - drug treatment (including opioid agonist therapy [OAT]), needle and syringe programmes (NSP) and other interventions - in the prevention of HCV and HIV transmission, and related measures of infection risk (IRB and injecting frequency [IF]), among PWID. We undertook an initial search for systematic reviews (i.e. an Overview of Reviews [OoR]) and subsequent systematic searches for primary studies where required. Where there was sufficient evidence based on synthesis of multiple robust studies for an intervention effect in the 2011 RoR, new evidence was not sought. Medline, CINAHL, The Cochrane Library, EMBASE, PsycINFO and Web of Science were searched (2011-2020). Two reviewers screened papers, extracted data, and graded reviews/studies. We classified evidence as 'sufficient', 'tentative', 'insufficient', or 'no evidence'. We screened 8513 reviews and 7133 studies, with 27 and 61 identified as relevant, respectively. The level of evidence increased since the 2011 RoR and is now 'sufficient' for OAT (regarding all outcomes), NSP (for reducing HIV transmission and IRB), and combination OAT/NSP (for reducing HCV transmission). There is also now sufficient evidence for in-prison OAT, psychosocial interventions, pharmacy-based NSP and provision of sterile drug preparation equipment for reducing IRB. There is now a strong body of empirical evidence for the effectiveness of OAT and NSP, alone and in combination, in reducing IRB, and HCV and HIV transmission. However, there is still a relative lack of evidence for other interventions, including heroin-assisted treatment, pharmacological treatment for stimulant dependence, contingency management, technology-based interventions, low dead space syringes and drug consumption rooms on HCV or HIV risk.

“Overdose Has Many Faces”: The Politics of Care in Responding to Overdose at Sydney’s Medically Supervised Injecting Centre

Drug consumption room literature often presents overdose as a stable phenomenon, which can be responded to in the same way from one context to the next. The literature is dominated by a clinical paradigm that implies that consumption rooms are effective because they provide sterile spaces and medical supervision, yet this is not the only way in which such services are delivered, nor is it the only component of the care provided at centers with a clinical focus. A growing body of critically oriented social science literature has highlighted the way different socio-material relations of care produce different capacities for service delivery. In order to expand the field’s understanding of care beyond an avowed a-political approach to clinical supervision, we conducted qualitative interviews with staff at Sydney Medically Supervised Injecting Centre (MSIC) about how they respond to overdose. Drawing on feminist notions of the politics of care we argue that overdoses are ontologically multiple phenomena, which are enacted at MSIC in ways that are explicitly differentiated from how they are understood and responded to in more traditional clinical settings. This illustrates how a desirable clinical intervention (saving lives) is made possible at MSIC through a set of constitutive relations (and politics) of care that are aimed at more than simply ensuring the client’s heart keeps beating.

Drug related harm reduction in the eu and candidate countries - success and gaps


 Background: Evaluation of the state of play of the 2003 Council Recommendation on the prevention and reduction of health-related harms, associated with drug dependence, in the EU and candidate countries and elaboration of proposals for new recommendations.
 Methods: Analysis of epidemiological data available at the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) using statistical modeling, a general literature review on harm reduction measures, four systematic literature reviews (one on peer naloxone pro-grams) and surveys among decision makers in the field of drug policy and among harm reduc-tion providers (“stakeholders”) using online questionnaires and a gap survey among the na-tional focal points of EMCDDA in EU-countries and candidate countries.
 Results: It was possible to decrease the number of HIV-infections among drug users substan-tially in most EU countries and candidate countries during the last decade; unfortunately for the numbers of deaths due to overdoses this effect could not be reached. Stakeholders (harm reduction providers) name improvement of needle and syringe exchange and harm reduction in prison as main priorities in order to reduce drug related infectious diseases. Concerning re-duction of mortality they prioritise peer naloxone programs, drug consumption rooms and first aid training of drug users.
 Conclusions : The increase of coverage of substitution treatment and of the availability of nee-dle exchange programs in most countries can be seen as successes of harm reduction policy although the coverage especially of the latter still needs improvement. Peer naloxone pro-grams and improvement of harm reduction in (and after) prison are two of 13 recommended actions to improve the situation concerning mortality of opioid users. Continuous political strengthening of harm reduction is necessary.

Developing harm reduction policies: Evidence from Copenhagen's drug consumption rooms.

Developing harm reduction policies: Evidence from Copenhagen's drug consumption rooms.

From the street to the drug consumption room. Injected drug use across consumption environments

Previous studies have reported that injected drug use cannot be understood in a spatiotemporal vacuum but, paradoxically, they have tended to analyze this practice in a single environment instead of examining how people who inject drugs deploy their agency across environments. This ethnographic account describes and analyzes how David, an injected cocaine user, moved from the streets of Barcelona to a drug consumption room By accounting his transition from exclusively consuming on the street to progressively increasing his visits to La Sala, we uncover how different practices, interactions, and norms, specific to these environments, can contribute to the shaping of the development of specific substance use and the techniques informing the complex relationship between pleasure and harm reduction. Accordingly, we argue that we cannot limit ourselves to analyzing this activity in each environment individually; rather, we must locate and study drug use at the interplay of different environments.

Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort.

The effectiveness of drug consumption rooms (DCRs) for people who inject drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and access to care for substance use disorders. However, data on other health-related complications are scarce. Using data from the French COSINUS cohort, we investigated the impact of DCR exposure on non-fatal overdoses, abscesses and emergency department (ED) visits, all in the previous 6 months. COSINUS is a 12-month prospective cohort study of 665 PWID in France studying DCR effectiveness on health. We collected data from face-to-face interviews at enrolment, and at 6 and 12 months of follow-up. After adjusting for other correlates (P-value < 0.05), the impact of DCR exposure on each outcome was assessed using a two-step Heckman mixed-effects probit model, allowing us to adjust for potential non-randomization bias due to differences between DCR-exposed and DCR-unexposed participants, while taking into account the correlation between repeated measures. At enrolment, 21%, 6% and 38% of the 665 participants reported overdoses, abscesses and ED visits, respectively. Multivariable models found that DCR-exposed participants were less likely to report overdoses [adjusted coefficient (95% CI): -0.47 (-0.88; -0.07), P = 0.023], abscesses [-0.74 (-1.11; -0.37), P < 0.001] and ED visits [-0.74 (-1.27; -0.20), P = 0.007]. This is the first study to show the positive impact of DCR exposure on abscesses and ED visits, and confirms DCR effectiveness in reducing overdoses, when adjusting for potential non-randomization bias. Our findings strengthen the argument to expand DCR implementation to improve PWID injection environment and health.

Drug Consumption Rooms and Public Health Policy: Perspectives of Scottish Strategic Decision-Makers.

There is widespread support for the introduction of Drug Consumption Rooms (DCRs) in Scotland as part of a policy response to record levels of drug-related harm. However, existing legal barriers are made more complex by the division of relevant powers between the UK and Scottish Governments. This paper reports on a national, qualitative study of key decision-makers in both local and national roles across Scotland. It explores views on the political barriers and enablers to the adoption of Drug Consumption Rooms and the potential role of these facilities in the wider treatment system. It also considers approaches to evidence, especially the types of evidence that are considered valuable in supporting decision-making in this area. The study found that Scottish decision-makers are strongly supportive of DCR adoption; however, they remain unclear as to the legal and political mechanisms that would make this possible. They view DCRs as part of a complex treatment and support system rather than a uniquely transformative intervention. They see the case for introduction as sufficient, on the basis of need and available evidence, thus adopting a pragmatic and iterative approach to evidence, in contrast to an appeal to traditional evidence hierarchies more commonly adopted by the UK Government.

Stakeholders’ Problematisation of Drug Consumption Rooms: A Case Study of the Policy Initiative in Helsinki

Drug consumption rooms are one of the harm reduction interventions to handle complex social problems. The Helsinki city initiative puts drug consumption room (DCR) on a government agenda in Finland, which has also triggered a broader discussion. This study presents how stakeholders problematise and what solutions they propose for DCRs. The research is based on in-depth interviews of 23 stakeholders and the theoretical perspective of Bacchi’s approach – ‘What’s the problem represented to be?’ (WPR). The results show that while stakeholders’ solutions resemble each other on the core DCR functions, the variations are found mainly in the introduction of extended services, policy development strategy, types of drug allowance in DCRs, and drug testing options. Stigmatisation of PWUDs still leads the harm reduction services to be considered from a moral framework. Stakeholders tend to take their positions according to strategic considerations related to electoral politics, expedience and the symbolic role of policies.

A Comprehensive Study on Sustainable Practices in the Hotel Industry: A Review

Ecological hotels are those that use green best practices in maintenance, services, logistics, goods, and supplies to considerably reduce their environmental effect. Hotels all around the world are implementing green measures, including smart bathrooms, solar power systems, and garbage diversion. Reducing energy and water consumption housekeeping and room service, are all part of moving toward sustainability. There are numerous hotels, ranging from the most basic to the most luxurious, are making efforts to improve their practices. As a result, the goals of this article are to: describe the features of sustainable practices in hotels, ii) investigate the many strategies for enhanced practices, and study the key procedures of sustainable practices. The research framework focuses on efforts that will improve awareness and sustainable development. The findings of this study will educate, motivate, and raise awareness among large and micro hotel company owners about the importance of working together to achieve sustainability.

What lessons from Europe's experience could be applied in the United States in response to the opioid addiction and overdose crisis?

What lessons from Europe's experience could be applied in the United States in response to the opioid addiction and overdose crisis?

Drug Consumption Rooms: Welfare State and Diversity in Social Acceptance in Denmark and in France.

Drug consumption rooms (DCRs) have the potential to have a positive impact on the opioid overdose crisis. DCRs could also potentially change the political environment for public health because they can affect the distribution of responsibility for harm reduction between the individual and society by collectivizing responsibility for harm reduction through welfare regimes. The methodology is based on 2 case studies-1 in Copenhagen, Denmark, and 1 in Paris, France-about residents, people who inject drugs (PWID), and politicians' experiences of DCRs involving semidirective interviews. Denmark has a long history of harm-reduction policy, and the implementation of DCRs in Copenhagen has happened through close collaboration between local authorities and the local community. France is far more centralized and paternalistic in terms of the distribution of authority and decision-making in welfare and drug policy. Difficulties in cohabitation between local residents and PWID happened in both countries and can sometimes make public authorities hesitate to implement DCRs because of the NIMBY ("not in my backyard") phenomenon. However, the Danish and French case studies show that DCRs have the potential to become an instrument for civic cohabitation as well as to contribute to the destigmatization and health of PWID. (Am J Public Health. 2022;112(S2):S159-S165. https://doi.org/10.2105/AJPH.2022.306808).

Overdose prevention centres in the UK

Overdose prevention centres in the UK

From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic

Drug-related deaths in Scotland increased for seven years in a row between 2014 and 2020 consolidating Scotland's place at the top of the United Kingdom and European drug-related mortality charts. One of the defining features of this recent and rapid rise has been the role of benzodiazepines which are now involved in two-thirds of all cases. Policy decisions over four decades have contributed to the supply and demand drivers of this unique element of the Scottish overdose crisis. An illicit market once populated by diverted prescription medications is now dominated by a toxic supply of NPS-type benzodiazepines or so-called 'street benzos' which have increased the risk environment for people who use drugs. In response, Scotland needs to urgently expand its harm reduction infrastructure and implement safer supply, drug testing and drug consumption rooms. Such a response should be made in parallel to addressing the socioeconomic inequalities which are fuelling an epidemic of global significance.

Policy windows for drug consumption rooms in Finland.

Background: Use of drug consumption rooms is a novel harm reduction approach to reach marginalised and isolated people who used drugs, under the high risk of overdose deaths and infectious diseases. The aim of this article was to evaluate the policy opportunities and barriers of the Helsinki City initiative for establishing the first drug consumption room (DCR) in Finland from the multiple streams framework. Method: A qualitative interview research method is used to evaluate the perspectives of stakeholders. By including 23 participants, we analysed the political, social and policy level advantages and disadvantages of the current initiative. Findings: Our results show that the cost of DCRs, the COVID-19 burdens on public resources, the requirement of legislative change, public unawareness, potential policy failure of DCRs, and its impacts on electoral votes constitute the main policy barriers. On the other hand, an increase in drug-related deaths, economic benefits of DCR for society, its effects on street safety and public order, being a local initiative, prospectus change in national drug strategy plans and motivation to catch up with EU standards were underlined as policy opportunities. Four issues, leadership, moral perspective, social change and generational differences, act as mediating factors, which are fluctuated according to public opinions and political environment. Conclusion: By applying the multiple streams framework, our results show that experts’ DCR problematisation is still beyond the public and political interest, which needs additional effort around problem identification and prioritisation. Besides public unawareness, the COVID-19 situation seems to be postponing policy progress since the primary attention and available funds have already been dedicated to public health. Already having a local initiative and an upcoming drug strategy plan might be good formal leverage, but unexpected events might also trigger discussions.